Trial Profile
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Apr 2019
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- Sponsors Allergan
- 12 Nov 2013 New trial record